studies have indicated that fluid shear stress induces the differentiation of EPCs into arterial ECs 5 ; this finding suggests that controlling the physical characteristics of the microenvironment may represent a method for optimizing EPC-based vascularization outcomes.
The vasculature is subdivided into two interconnected, yet structurally and functionally distinct, networks of arteries and veins. They form one of the body's largest surfaces, which serves as a critical interface between the circulation and the different organ microenvironments. Among the microenvironmental cues, matrix stiffness is a universal mechanical input that profoundly controls cell behaviour, including differentiation. 6, 7 The range of venous tissue stiffness in mammals, which is between the stiffness of the epithelium and cartilage, ranges from 3 to 50 kPa. [8] [9] [10] Unlike veins, arteries can withstand a higher blood pressure and are surrounded by several layers of smooth muscle cells and connective tissues. 11 Therefore, arteries are stiffer, with stiffness ranging from approximately 50 to 150 kPa or higher. 12, 13 However, when these stiffness values are compared with those of the glass or plastic containers used for tissue culture, such as Petri dishes (~10 6 kPa), it becomes apparent that the microenvironment in which most cells are cultured in vitro is not representative of the physiological scenario. Accordingly, in order to design matrices to the specific requirements of diverse tissues, it is necessary to develop well-defined biomaterials that mimic the matrices of the vasculature and enable the reliable control of functional vascularization.
With this in mind, we first developed a stiffness-adjustable dextran hydrogel model. Mouse bone marrow-derived EPCs were cultured in the hydrogels to form vascular networks following in vivo implantation to investigate the effect of matrix stiffness on the arterial-venous differentiation of EPCs. We further explored the precise mechanism by which matrix stiffness regulates the expression of arterial and venous markers in the new vessels. Our work provides a potential method for adapting EPC-based vascularization to the specific requirements of a diverse range of tissues, thus, representing a substantial advancement in regenerative medicine.
| MATERIAL S AND ME THODS

| Cell culture and identification
This investigation conformed to the governing ethical principles, and the protocols were approved by the Institutional Review Board (IRB)
of Sichuan University. 
| Fabrication of dextran hydrogels of varying stiffnesses
The hydrogel preparation method was based on the non-cytotoxic crosslinking of maleimide-modified dextran polymers with thiol-reactive groups (mal-dextran) and crosslinkers with thiol groups (CDlink) (3-D Life Hydrogel, pH 7.2, Reutlingen, Germany). To adjust the stiffness of the hydrogel-based extracellular matrix (ECM), dextran hydrogel (300 μL) containing different concentrations of mal-dextran and CD-link was added. The gels were prepared by sequentially mixing sterile components (Table 1) such as (a) water, 10× concentration buffer, and the polymer of dextran were combined in a reaction tube and mixed well; (b) the cell suspension or medium was added;
(c) CD-link was added and the suspension was mixed by pipetting up and down; (d) once the gel formed, it was covered in cell culture medium; (e) the culture dish was placed in the incubator; (6) the medium was renewed after 50 minutes.
The stiffness of the final mixture was estimated based on the weight-induced compression of the matrix and calculated according to the equation:
where E is Young's modulus, F is the force exerted on the gel, A 0 is the original cross-sectional area through which the force is applied, ΔL is the change in the thickness of the gel and L 0 is the initial thickness of the gel. The thicknesses of the hydrogel before and after force loading were determined microscopically.
| Animal model
First, EPC-containing dextran hydrogels were prepared. Based on the required ratios for the two groups of hydrogels at concentrations of 2.0 and 7.0 mmol/L (Table 1) Next, we subcutaneously injected the 300 μL hydrogel complexes in the left (6 kPa) and right (109 kPa) sides of the backs of the nude mice before crosslinking ( Figure 3A ). After 14 days, the hydrogels were surgically removed and washed with PBS.
| Tissue sectioning
The hydrogels from the nude mice were fixed in 10% formaldehyde for 4 hour. After fixation, the hydrogels were dehydrated sequentially with 80%, 90%, 95% and 100% ethanol I, then 100% ethanol II and 100% ethanol III, and cleared with xylene I and xylene II for 30 minutes each. The samples were immersed in paraffin wax I for 1 hour and paraffin wax II for 5 hour. The samples were embedded in paraffin wax with the material surface for sampling facing downward. After the wax block cooled and solidified, the samples were frozen at −20°C and sliced to a thickness of 4 μm.
| Immunohistochemical staining to identify in vivo vasculogenesis
The sections were dewaxed with xylene I for 20 minutes and xylene The prepared primary anti-CD31 antibody (77699s, CST, USA) was added dropwise to the samples, which were incubated at 4°C overnight. The resulting mixture was allowed to settle for 30 minutes,
washed with PBS, incubated with the secondary antibody at 37°C
for 30 minutes. Next, the samples were stained with 3,3'-diaminobenzidine (ZSGB-BIO, Beijing, China); the progress of the reaction was monitored under a microscope until completion, and then, the samples were thoroughly rinsed with ultrapure water. Finally, the samples were counterstained with haematoxylin (Sigma, USA), dried, sealed and photographed.
| Detection of arteriovenous markers with double-label immunofluorescence staining
Sectioning was performed as described above. Then, the samples The samples were imaged using confocal laser scanning microscopy (Leica TCS SP8, Wetzlar, Germany). The fluorescent staining was statistically analysed with ImageJ software. TA B L E 1 Reagent volumes for the setup of hydrogels at different stiffness
| Quantitative real-time PCR
Briefly, total RNA was extracted from EPCs using the RNeasy Plus
Mini Kit (Qiagen, Hilden, Germany), and the reverse transcription and 32 seconds at 60°C. For each reaction, a melting curve was generated to test for primer dimer formation and false priming. The sequences of the forward and reverse primers are listed in Table 2 .
| Western blot analysis
Protein samples were mixed with Bio-Rad Laemmli Sample Buffer and then boiled at 100°C for 5 minutes. Proteins were separated by electrophoresis in 10% acrylamide gels containing SDS and transferred onto polyvinylidene difluoride membranes at 200 mA for 1 hour.
Membranes were blocked with 5% BSA for 1 hour prior to incubation 
| Artificial degradation of dextran hydrogels
The hydrogels were artificially degraded with dextranase (3-D Life
Hydrogel, Reutlingen, Germany) to extract mRNA and protein. First, the dextranase was diluted in M199 medium (v/v, 1:20). Then, the hydrogels were soaked in the dextranase solution (3 mL; v/v, 1:10) at 37°C for 50 minutes. After the hydrogels had dissolved, we subjected the resulting tissues to centrifugation and washed twice with PBS to ensure effective removal of the dextranase and the dissolved gel components.
| Inhibitor experiments
We treated the animal experimental group implanted with 109 kPa hydrogel with FTS (20 μmol/L, diluted with PBS) and the control group implanted with 6 kPa hydrogel with PBS. Starting on day 2, we injected the hydrogel samples implanted in the nude mice with the FTS solution (right) and PBS (left) every 24 hour (injection volume, 150 μL/side). After 14 days, the hydrogels were removed and digested as above. The samples were subjected to quantitative polymerase chain reaction (qPCR) and Western blotting to detect the gene transcription and protein expression levels of Efnb2 and Ephb4.
| Statistical analysis
All experiments were repeated for at least three times, independently. Statistical analysis of data was performed with the SPSS statistical software version 21.0 (IBM, Armonk, NY, USA) using t test.
In each analysis, data were considered to be significantly different when the two-tailed P value was <0.05. 
| RE SULTS
| Identification of EPCs
Image of the obtained cells observed by a microscope was shown in Figure 1A . Flow cytometric analysis first revealed that CD31 
| Assessment of the dextran hydrogels of tunable stiffness
The hydrogels with different compositional ratios were added to a 48-well plate. After 50 minutes, the hydrogels were fully crosslinked. Moreover, the hydrogels with concentrations of 2.0 and 7.0 mmol/L had stiffnesses in the ranges of the venous ECM and arterial ECM, respectively. Therefore, in the following in vivo experiments, we selected these two dextran hydrogels to mimic the venous and arterial ECM for EPC cultures, which we referred to as the 6 kPa group and 109 kPa group, respectively.
| Analysis of EPC morphology on matrices of varying stiffness
First, we investigated the response of EPCs to microenvironmental stiffness via the dynamics of the cytoskeletal network. Phalloidin staining of the cell cytoskeleton indicated that there were apparent differences in cellular morphology and cytoskeletal filament arrangements on matrices of varying stiffness. The EPCs cultured on the surfaces of the soft matrices were ovoid with a small cell spreading area, and their internal cytoskeletal filaments were short, slender, and were unable to form obvious filament bundles. On stiffer matrices, the cytoskeleton filaments were elongated and formed crosslinked filament bundles and a larger EPC spreading area ( Figure 2C ). In addition, we quantitatively analysed the cell spreading area and reached the same conclusion: cell spreading area increases with increasing matrix stiffness ( Figure 2D-E) .
| In vivo vasculogenesis during culture of the hydrogel-EPC composites
The hydrogels with different stiffnesses were translucent, and blood vessels were visible in both the soft and hard hydrogels ( Figure 3B-C) .
Next, we assessed the nature of the tubular structures within the hydrogels by immunohistochemistry. The tubular structures in the hydrogels were labelled with the anti-CD31 antibody ( Figure 3D ), demonstrating that the newly formed tubular structures in the hydrogels were vascular structures.
| Detection of the arteriovenous markers Efnb2 and Ephb4
In our study, new vessels cultured on both hydrogels simultaneously expressed the arterial endothelial marker Efnb2 and the venous endothelial marker Ephb4. The expression of Efnb2 in the 109 kPa hydrogel was higher than that in the 6 kPa hydrogel, whereas Ephb4 showed the opposite expression pattern ( Figure 4A-B) .
Real-time qPCR analysis indicated that the mRNA level of Efnb2
in the 109 kPa group was 3.63 × higher than that in the 6 kPa group. In contrast, the mRNA level of Ephb4 in the 109 kPa group was 36.4% of that in the 6 kPa group. Thus, the mRNA expression of the Efnb2 gene increased with the stiffness of the hydrogel matrix, whereas the transcription level of the Ephb4 gene showed the opposite trend ( Figure 4C ).
Western blotting further confirmed that the expression of the arterial marker increased with increasing matrix stiffness, whereas the venous marker showed the opposite trend. Consistent with the results of immunofluorescence staining, the protein expression levels of Efnb2 and Ephb4 in the 109 kPa group were 1.71 × and 0.61 × those in the 6 kPa group, respectively ( Figure 4D ).
| Mechanotransduction and underlying intracellular signalling pathways
Next, we investigated the potential signalling pathways involved in the mechanotransduction process. In our study, the expressions of Ras and Mek were upregulated in the 109 kPa group at both the mRNA and protein levels ( Figure 5A-C) . The upregulation of RhoA could also be observed, which further contributed to the activation of the Ras pathway. 14, 15 A number of other studies have confirmed that changes in the Ras/Mek pathway affect the Notch pathway and that activation of the Notch pathway promotes arterial differentiation and inhibits the expression of vein-related marker proteins.
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F I G U R E 4 A, Double immunofluorescence staining of arteriovenous marker proteins (scale, 10 μm) in hydrogels with different stiffnesses; B, Statistical analysis of the fluorescence intensities. Each experimental value is expressed as the mean ± standard deviation; C, Gene transcript levels of the arteriovenous markers in the newly formed vessels in the hydrogels of different stiffnesses. All groups of genes were first normalized to internal references, then normalized to the control group (6 kPa group); D, Western blotting for and statistical analysis of Efnb2 and Ephb4 expression in the newly formed vessels in the hydrogels of different stiffnesses. Data shown were representative of three independent experiments; *P < 0.05, ** P < 0.01, ***P < 0.001
In this work, we found that both the mRNA and the protein levels of Notch1 were elevated in the 109 kPa group along with its downstream protein Hey1. Further, consistent with our previous study and other experimental reports, [17] [18] [19] [20] activation of the Notch pathway can inhibit the expression of VEGFR3 ( Figure 5D-F) .
| Results of inhibitor experiments
The Ras signalling inhibitor farnesylthiosalicylic acid (FTS) was used to verify the role of the Ras/Mek signalling pathway in the matrix stiffness-mediated regulation of the arteriovenous differentiation of EPCs. In the experimental 109 kPa group treated with the Ras/ Mek pathway inhibitor FTS, the Efnb2 and Ephb4 gene levels did not statistically differ from those in the control 6 kPa group ( Figure 6A ).
Western blotting revealed that treatment with the inhibitor prevented significant enhancement of the expression of the arterial marker Efnb2 in the hard hydrogel and even slightly decreased its expression ( Figure 6B ). There were no significant differences in the expression of Efnb2 or Ephb4 between the two groups in the pres- 
| Effect of matrix stiffness on cell morphology
The process through which cells respond to ECM stiffness is also the process through which cells achieve a dynamic balance between their contraction tension and the ECM force. 25 
| In vivo vasculogenesis during culture of the hydrogel-EPC composites
Vasculogenesis is the process in which desired new blood vessels are produced by close interactions between ECM, seed cells and growth factors. 30 We performed a number of preliminary experiments in this study to determine the optimal experimental conditions for in vivo vasculogenesis in nude mice. We found that the EPC-free hydrogels implanted into nude mice did not show vascular structure formation after 14 days, even when the hydrogels were seeded with In this experiment, we examined the gene and protein levels of arteriovenous markers in the blood vessels that were generated in vivo. Efnb2 and Ephb4 had opposite expression patterns in dextran hydrogels of differing stiffnesses. The expression of Efnb2 increased and the expression of Ephb4 decreased with increased matrix stiffness, which indicates that a stiffer matrix can promote the differentiation of EPCs into arteries, whereas a softer matrix can promote differentiation into veins.
| Mechanism exploration
Studies on the morphologies of EPCs on matrices of different stiffnesses have shed light on the important role of the ECM-integrinactin system for the transduction of matrix stiffness mechanical signals. 35 The interactions between EPCs and the ECM initiate a series of reactions to convert mechanical signals into biochemical signals that affect the outcomes of cells. External physical signals from the ECM activate the superfamily of small GTP-binding proteins through integrins. 36 The superfamily of small GTPbinding proteins can be divided into three major subfamilies as follows: Ras, Rho and Rab. 37 Ras molecules are members of the superfamily of small GTP-binding proteins, and the related signal transduction pathway Ras/Raf/Mek/Erk, also known as the Ras/ Mek signalling pathway, is considered the "master switch" of many mechanically transduced signals. 38 Moreover, the Notch pathway, which is closely associated with the Ras/Mek pathway, is an important signalling pathway in the regulation of vasculogenesis, vascular growth and differentiation. 39 The Notch1 protein is an arterial marker. Therefore, matrix stiffness as a physical signal may be linked to arterial and venous phenotypes through the Ras/Mek signalling pathway and the Notch pathway. 40 Ras and RhoA can be directly activated by matrix stiffness signals and the upregulation of RhoA activates Ras, which means that matrix stiffness can activate the Ras signalling pathway directly and indirectly. [41] [42] [43] A number of other studies have confirmed that changes in the Ras/Mek pathway affect the Notch pathway and that activation of the Notch pathway promotes arterial differentiation and inhibits the expression of vein-related marker proteins.
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Based on our results and the published literature, we propose a mechanism for the regulation of arteriovenous differentiation of 
48-51
Notch1 and Hey1 are arterial markers, and VEGFR3 is a venous marker. The trends we detected in the changes in the expression of these markers were largely consistent with the trends in the changes of Efnb2 and Ephb4 expression. Enhanced arterial marker expression and decreased venous marker expression are associated with increased matrix stiffness. Therefore, the results of our research on the mechanism of action support our conclusion that the arteriovenous differentiation of EPCs is regulated by matrix stiffness.
| CON CLUS IONS
In summary, matrix stiffness regulates the arteriovenous differentiation of endothelial progenitor cells during vasculogenesis in nude mice through the Ras/Mek pathway: arterial lineages were obtained on stiff substrates while venous commitment predominated in the softer matrix. Therefore, the stiffness of the matrix must be considered when conducting vascularized material design, drug testing and cell therapies to meet tissue-and organ-specific vascularization requirements.
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